supplement is based on two symposia sponsored by Glaxo
Wellcome. The first was on Monotherapy and Polytherapy
in Epilepsy held at the 32nd Canadian Congress of Neurological
Sciences in Saskatoon, Saskatchewan in June, 1997. The
second was a continuing medical education program for
neurologists on epilepsy held at Glaxo Wellcome offices
in Mississauga, Ontario in September, 1997.